Hypoxia-inducible factor-1 and oncogenic signalling

被引:164
作者
Bárdos, JI [1 ]
Athcroft, M [1 ]
机构
[1] Inst Canc Res, Ctr Canc Therapeut, Cell Growth Regulat & Angiogenesis Lab, Sutton SM2 5NG, Surrey, England
关键词
D O I
10.1002/bies.20002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An understanding of underlying mechanisms Involved in the activation of HIF-1 in response to both hypoxic stress and oncogenic signals has important implications for how these processes may become deregulated in human dancer. Changes in microenvironmental stimuli such as hypoxia and growth factors in combination With genetic lesions such as loss or inactivation of p53, PTEN or pVHL or oncogenic activation, can all lead to increased HIF-1 activity This provides cancer cells With a distinct ad Vantage for survival and proliferation, resulting in their ability to form vascular tumours, which are aggressive and metastatic. Accordingly, upregulation of HIF-1alpha, a key component of HIF-1, correlates with a poor treatment outcome Using conventional therapies. A Variety of mechanisms exist that regulate expression of HIF-lalpha. In recent years, it has become clear that an extensive network of signalling cascades converge on HIF-1alpha to regulate the transcriptional response. A better understanding of this regulation may provide 6 basis for the development of new cancer therapies. BioEssays 26:M 269, 2004. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:262 / 269
页数:8
相关论文
共 84 条
  • [41] Regulation of p53 by hypoxia: Dissociation of transcriptional repression and apoptosis from p53-dependent transactivation
    Koumenis, C
    Alarcon, R
    Hammond, E
    Sutphin, P
    Hoffman, W
    Murphy, M
    Derr, J
    Taya, Y
    Lowe, SW
    Kastan, M
    Giaccia, A
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (04) : 1297 - 1310
  • [42] FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor
    Lando, D
    Peet, DJ
    Gorman, JJ
    Whelan, DA
    Whitelaw, ML
    Bruick, RK
    [J]. GENES & DEVELOPMENT, 2002, 16 (12) : 1466 - 1471
  • [43] Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch
    Lando, D
    Peet, DJ
    Whelan, DA
    Gorman, JJ
    Whitelaw, ML
    [J]. SCIENCE, 2002, 295 (5556) : 858 - 861
  • [44] HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis:: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
    Laughner, E
    Taghavi, P
    Chiles, K
    Mahon, PC
    Semenza, GL
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (12) : 3995 - 4004
  • [45] Mabjeesh NJ, 2003, CLIN CANCER RES, V9, P2416
  • [46] FIH-1:: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
    Mahon, PC
    Hirota, K
    Semenza, GL
    [J]. GENES & DEVELOPMENT, 2001, 15 (20) : 2675 - 2686
  • [47] Activation of the HIF pathway in cancer
    Maxwell, PH
    Pugh, CW
    Ratcliffe, PJ
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2001, 11 (03) : 293 - 299
  • [48] The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
    Maxwell, PH
    Wiesener, MS
    Chang, GW
    Clifford, SC
    Vaux, EC
    Cockman, ME
    Wykoff, CC
    Pugh, CW
    Maher, ER
    Ratcliffe, PJ
    [J]. NATURE, 1999, 399 (6733) : 271 - 275
  • [49] BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin
    Mayerhofer, M
    Valent, P
    Sperr, WR
    Griffin, JD
    Sillaber, C
    [J]. BLOOD, 2002, 100 (10) : 3767 - 3775
  • [50] Mazure NM, 1996, CANCER RES, V56, P3436